NIAID Banner Logo Image

HIV Citations List: January, 2020

Literature Citations

1. Synthesis, Molecular Docking and Biological Evaluation of 2-(Thiophen-2-yl)-1H-indoles as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. El-Hussieny, M., N.F. El-Sayed, E.F. Ewies, N.M. Ibrahim, M.R.H. Mahran, and M.A. Fouad. Bioorganic Chemistry, 2020. 95: 103521. PMID[31884145].
[PubMed]. HIV_01_2020.

2. Fragment Hopping-based Discovery of Novel Sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors. Han, S., Y. Sang, Y. Wu, Y. Tao, C. Pannecouque, E. De Clercq, C. Zhuang, and F.E. Chen. European Journal of Medicinal Chemistry, 2020. 185: 111874. PMID[31735575].
[PubMed]. HIV_01_2020.

3. Potent Inhibition of HIV Replication in Primary Human Cells by Novel Synthetic Polyketides Inspired by Aureothin. Herrmann, A., M. Roesner, T. Werner, S.M. Hauck, A. Koch, A. Bauer, M. Schneider, and R. Brack-Werner. Scientific Reports, 2020. 10(1): 1326. PMID[31992748]. PMCID[PMC6987146].
[PubMed]. HIV_01_2020.

4. Design, Synthesis and Biological Evaluation of Imidazole and Oxazole Fragments as HIV-1 Integrase-LEDGF/p75 Disruptors and Inhibitors of Microbial Pathogens. Rashamuse, T.J., A.T. Harrison, S. Mosebi, S. van Vuuren, E.M. Coyanis, and M.L. Bode. Bioorganic & Medicinal Chemistry, 2020. 28(1): 115210. PMID[31753802].
[PubMed]. HIV_01_2020.

5. A Novel Isothiocyanate Derivative Inhibits HIV-1 Gene Expression and Replication by Modulating the Nuclear Matrix Associated Protein SMAR1. Trivedi, J., A. Alam, S. Joshi, T.P. Kumar, V. Chippala, P.S. Mainkar, S. Chandrasekhar, S. Chattopadhyay, and D. Mitra. Antiviral Research, 2020. 173: 104648. PMID[31706900].
[PubMed]. HIV_01_2020.

6. Computational Design, Synthesis and Evaluation of New Sulphonamide Derivatives Targeting HIV-1 gp120.Vangala, R., S.K. Sivan, S.R. Peddi, and V. Manga. Journal of Computer-Aided Molecular Design, 2020. 34(1): p. 39-54. PMID[31792886].
[PubMed]. HIV_01_2020.

7. Indazolyl-substituted Piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, Synthesis and Biological Activities. Xiao, T., J.F. Tang, G. Meng, C. Pannecouque, Y.Y. Zhu, G.Y. Liu, Z.Q. Xu, F.S. Wu, S.X. Gu, and F.E. Chen. European Journal of Medicinal Chemistry, 2020. 186: 111864. PMID[31767136].
[PubMed]. HIV_01_2020.

8. Rational Design and Structure-Activity Relationship of Coumarin Derivatives Effective on HIV-1 Protease and Partially on HIV-1 Reverse Transcriptase. Zhu, M., L. Ma, J. Wen, B. Dong, Y. Wang, Z. Wang, J. Zhou, G. Zhang, J. Wang, Y. Guo, C. Liang, S. Cen, and Y. Wang. European Journal of Medicinal Chemistry, 2020. 186: 111900. PMID[31771827].
[PubMed]. HIV_01_2020.

9. Preliminary SAR and Biological Evaluation of Potent HIV-1 Protease Inhibitors with Pyrimidine Bases as Novel P2 Ligands to Enhance Activity against DRV-Resistant HIV-1 Variants.Zhu, M., L. Ma, H. Zhou, B. Dong, Y. Wang, Z. Wang, J. Zhou, G. Zhang, J. Wang, C. Liang, S. Cen, and Y. Wang. European Journal of Medicinal Chemistry, 2020. 185: 111866. PMID[31734023].
[PubMed]. HIV_01_2020.

Patent Citations

10. Antibodies That Target HIV gp120 and Methods of Use. Balakrishnan, M., B.A. Carr, M.S. Hung, M. Kanwar, C.S. Pace, D. Rehder, M.R. Schenauer, L. Serafini, H.T. Stephenson, N.D. Thomsen, H. Yu, and X. Zhang. Patent. 2020. 2020-WO2020010107A1 20200109: 291pp.
[Patent]. HIV_01_2020.

11. Capsid Inhibitors for the Treatment of HIV.Bauer, L.E., A. Chiu, E.M. Gorman, A.S. Mulato, M.S. Rhee, C.W. Rowe, S.P. Sellers, D. Stefanidis, W.C. Tse, and S.R. Yant. Patent. 2020. 2020-US2020038389A1 20200206: 112pp.
[Patent]. HIV_01_2020.

12. Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Belema, M., K.J. Eastman, E.P. Gillis, J.F. Kadow, B.N. Naidu, and K.E. Parcella. Patent. 2020. 2020-WO2020003093A1 20200102: 103pp.
[Patent]. HIV_01_2020.

13. Methods for Reversing HIV Latency Using BAF Complex Modulating Compounds. Crabtree, G.R., E.C. Dykhuizen, and T. Mahmoudi. Patent. 2020. 2020-WO2020014524A1 20200116: 84pp.
[Patent]. HIV_01_2020.

14. Triterpene amine Derivatives.Freed, E.O., D.E. Martin, T.J. Nitz, and C.T. Wild. Patent. 2020. 2020-WO2020006510A1 20200102: 251pp.
[Patent]. HIV_01_2020.

15. Engineered Antibodies to HIV Env.Jardine, J. and D. Sok. Patent. 2020. 2020-WO2020023827A1 20200130: 267pp.
[Patent]. HIV_01_2020.

16. Anti-HIV Compounds. Korniy, N., F. Peske, M.V. Rodnina-Wintermeyer, and E. Samatova. Patent. 2020. WO2020020935A1 20200130: 45pp.
[Patent]. HIV_01_2020.

17. Phosphinic amide Prodrugs of Tenofovir. Raheem, I., M. Rudd, and M.d.L. Ruiz. Patent. 2020. 2020-WO2020018399A1 20200123: 62pp.
[Patent]. HIV_01_2020.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2020